This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources Jan. 25, 2011
 
ASCLS eNewsBytes
Jan. 25, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources
 
 

ASCLS Touch Briefings Journals
U.S. Endocrinology — Volume 6    Share   Share on FacebookTwitterShare on LinkedinE-mail article
ASCLS collaborates with Touch Briefings to bring ASCLS members free access to the latest eBook versions of the following journals: U.S. Oncological Review Volume 6, U.S. Cardiology Volume 7 issue 2, U.S. Endocrinology Volume 6.

For more information on Touch Briefings' clinical journals, please visit: www.touchoncology.com, www.touchcardiology.com and www.touchendocrinology.com.
More




Thrombotic thrombocytopenic purpura and urinary tract infections: Is there a connection?
American Journal of Clinical Pathology via Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Idiopathic thrombotic thrombocytopenic purpura, a thrombotic microangiopathic anemia, has no known stimulus. The disease, commonly seen in previously healthy people, is characterized by microangiopathic hemolytic anemia and thrombocytopenia without any other likely causes. Most patients with idiopathic TTP have a deficiency in activity of ADAMTS13, a von Willebrand factor -cleaving pro-tease, and demonstrate an associated autoantibody. Before the routine use of therapeutic plasma exchange to treat patients with TTP, the mortality was approximately 90 percent. More

Blocking a gene stops cancer cells spreading
BBC    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A gene which encourages cancer to move around the body has been discovered. Experiments on tissue cultures, published in Oncogene, suggest that blocking it would prevent cancers spreading. The researchers hope their work will lead to a new generation of cancer drugs within the decade. More

California's City of Hope team develops 'smart bomb'
to neutralize HIV

San Jose Mercury News    Share    Share on FacebookTwitterShare on LinkedinE-mail
article
After several years in the lab, researchers at City of Hope in Duarte, Calif., are reporting positive results in animal trials of a new treatment designed to both hunt down HIV-infected cells and stop the virus from spreading, according to a study published in the journal, "Science Translational Medicine." John Rossi, chair of molecular and cellular biology at City of Hope and a lead author on the study, likens the molecular compound his team designed to a "smart bomb." It works against the virus itself, while delivering a potent "weapon" to the inside of infected cells, where HIV multiplies. More



No effect from IV iron added to ESA, in contrast to previous studies
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail
article
A new study — the largest to date — has found no additional effect from adding intravenous (IV) iron to an erythropoiesis-stimulating agent (ESA) in cancer patients with chemotherapy-associated anemia. The study, by David Steensma, MD, and colleagues at the Dana-Farber Cancer Institute, Harvard Medical School in Boston, appears in the the Journal of Clinical Oncology. The negative result is in sharp contrast to a number of positive studies that have shown benefit from adding IV iron in this setting, as previously reported by Medscape Medical News. More

Rapid stem cell culture promises cartilage repair
Laboratory News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers from the University of Manchester and Central Manchester NHS Foundation Trust took human embryonic stem cells and developed a culture procedure programming the cells' development with a timed series of culture conditions containing different added nutrients to ensure they only produced chondrocytes — the cells that go on to form cartilage. More

Antibodies help seriously ill H1N1 patients recover
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail
article
Patients who fell severely ill with the pandemic H1N1 flu responded well when treated with antibodies harvested from survivors of the disease, a study in Hong Kong has found. The finding, published in the journal Clinical Infectious Diseases, underlines the importance of using antibodies from recovered patients to treat critically ill people who fail to respond to standard drugs, said lead author Kwok-yung Yuen, a virologist at the University of Hong Kong. More

Bird flu detected on Japanese chicken farm
United Press International    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The slaughter of more than 10,000 chickens was ordered recently on a Japanese farm after avian influenza was detected in six birds, officials said. The prefectural government in Miyazaki also imposed a six-mile quarantine area around the farm where the infected birds were found, The Mainichi Daily News reported. That means no eggs or birds can be transferred within the area until the restrictions are lifted. More
 
 
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Colby Horton, Vice President of Publishing
469.420.2601

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor
469.420.2641.

Recent Issues

  • Jan. 18, 2011
  • Jan. 11, 2011
  • Jan. 4, 2011
  • Dec. 28, 2010
  • Dec. 21, 2010
  •  RSS Feed
    Most popular articles